Search results - ORA - Oxford University Research Archive

1

Journal article

Changes over time in creatinine clearance and comparison of emergent adverse events for HIV-positive adults receiving standard doses (300 mg/day) of lamivudine-containing antiretroviral therapy with baseline creatinine clearance of 30-49 vs ≥50 mL/min

Ross, LL, Walker, AS, Lou, Y, et al.
2019-11-14

2

Journal article

Cost Effectiveness Analysis of Clinically Driven versus Routine Laboratory Monitoring of Antiretroviral Therapy in Uganda and Zimbabwe

Lara, A, Kigozi, J, Amurwon, J, et al.
2012-04-24

3

Journal article

Lopinavir/ritonavir monotherapy after 24 weeks of second-line antiretroviral therapy in Africa: a randomized controlled trial (SARA).

Gilks, C, Walker, A, Dunn, D, et al.
2012-01-01

4

Journal article

Estimating glomerular filtration rate in HIV-infected adults in Africa: comparison of Cockcroft-Gault and Modification of Diet in Renal Disease formulae.

Stöhr, W, Walker, A, Munderi, P, et al.
2008-01-01

5

Journal article

High level of viral suppression and low switch rate to second-line antiretroviral therapy among HIV-infected adult patients followed over five years: retrospective analysis of the DART trial

Kityo, C, Gibb, D, Gilks, C, et al.
2014-03-13

6

Journal article

Doxycycline prophylaxis in malaria.

Gilks, C, Peto, T
1987-06-01

7

Journal article

A single CD4 test with 250 cells/mm3 threshold predicts viral suppression in HIV-infected adults failing first-line therapy by clinical criteria

Gilks, C, Walker, A, Munderi, P, et al.
2013-02-21

8

Journal article

The Impact of Different CD4 Cell-Count Monitoring and Switching Strategies on Mortality in HIV-Infected African Adults on Antiretroviral Therapy: An Application of Dynamic Marginal Structural Models.

Ford, D, Robins, J, Petersen, M, et al.
2015-10-01

9

Journal article

Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial.

Mugyenyi, P, Walker, A, Hakim, J, et al.
2010-01-01

10

Journal article

Distribution of HLA-B alleles in a Ugandan HIV-infected adult population: NORA pharmacogenetic substudy of DART.

Munderi, P, Snowden, W, Walker, A, et al.
2011-02-01

11

Journal article

Prevalence, incidence and predictors of severe anaemia with zidovudine-containing regimens in African adults with HIV infection within the DART trial.

Ssali, F, Stöhr, W, Munderi, P, et al.
2006-01-01

12

Journal article

CD8 T-Cell Responses before and after Structured Treatment Interruption in Ugandan Adults Who Initiated ART with CD4 T Cells <200 Cell/μL: The DART Trial STI Substudy.

Serwanga, J, Mugaba, S, Betty, A, et al.
2011-01-18

13

Journal article

Patterns of individual and population-level adherence to antiretroviral therapy and risk factors for poor adherence in the first year of the DART trial in Uganda and Zimbabwe.

Muyingo, S, Walker, A, Reid, A, et al.
2008-08-01

14

Journal article

Nevirapine/zidovudine/lamivudine has superior immunological and virological responses not reflected in clinical outcomes in a 48-week randomized comparison with abacavir/zidovudine/lamivudine in HIV-infected Ugandan adults with low CD4 cell counts.

Munderi, P, Walker, A, Kityo, C, et al.
2010-05-01

15

Journal article

A polymorphism that reduces RANTES expression is associated with protection from death in HIV-seropositive Ugandans with advanced disease.

Cooke, G, Tosh, K, Ramaley, P, et al.
2006-09-01

16

Journal article

A CD45 polymorphism associated with abnormal splicing is absent in African populations.

Tchilian, E, Dawes, R, Ramaley, P, et al.
2002-02-01

17

Journal article

Pharmacokinetics of lopinavir-ritonavir with and without nonnucleoside reverse transcriptase inhibitors in Ugandan HIV-infected adults.

Kityo, C, Walker, A, Dickinson, L, et al.
2010-07-01

18

Journal article

CLUSTERS OF SHINGLES

Peto, T, Gilks, C, Jueljensen, B
1985-01-01

19

Journal article

Glomerular dysfunction and associated risk factors over 4-5 years following antiretroviral therapy initiation in Africa.

Stöhr, W, Reid, A, Walker, A, et al.
2011-01-01

20

Journal article

Daily co-trimoxazole prophylaxis in severely immunosuppressed HIV-infected adults in Africa started on combination antiretroviral therapy: an observational analysis of the DART cohort.

Walker, A, Ford, D, Gilks, C, et al.
2010-04-01

21

Journal article

Severe renal dysfunction and risk factors associated with renal impairment in HIV-infected adults in Africa initiating antiretroviral therapy.

Reid, A, Stöhr, W, Walker, A, et al.
2008-04-01

22

Journal article

HIV in Africa (Communication arising): chemokine-receptor genes and AIDS risk.

Ramaley, P, French, N, Kaleebu, P, et al.
2002-05-01

23

Journal article

DART and laboratory monitoring of HIV treatment Reply

Walker, A, Mugyenyi, P, Munderi, P, et al.
2010-03-20

24

Journal article

A CD45 polymorphism associated with abnormal splicing is absent in African populations

Tchilian, E, Dawes, R, Ramaley, P, et al.
2002-02-01

25

Journal article

Mortality in the year following antiretroviral therapy initiation in HIV-infected adults and children in Uganda and Zimbabwe.

Walker, A, Prendergast, A, Mugyenyi, P, et al.
2012-12-01

26

Journal article

Pregnancy and infant outcomes among HIV-infected women taking long-term ART with and without tenofovir in the DART trial.

Gibb, D, Kizito, H, Russell, E, et al.
2012-01-01

27

Journal article

Viral rebound and emergence of drug resistance in the absence of viral load testing: a randomized comparison between zidovudine-lamivudine plus Nevirapine and zidovudine-lamivudine plus Abacavir.

Ndembi, N, Ndembi, N, Goodall, R, et al.
2010-01-01

EXPLORE THE UNIVERSITY OF OXFORD'S WORLD-CLASS RESEARCH